TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,489,000 | +81.1% | 198,699 | 0.0% | 1.27% | +85.1% |
| Q2 2021 | $1,927,000 | -9.7% | 198,699 | 0.0% | 0.68% | -25.0% |
| Q1 2021 | $2,134,000 | -17.0% | 198,699 | +13.7% | 0.91% | -21.5% |
| Q4 2020 | $2,570,000 | +2.6% | 174,699 | -0.9% | 1.16% | -20.8% |
| Q3 2020 | $2,504,000 | +17.1% | 176,215 | -33.3% | 1.47% | +25.9% |
| Q2 2020 | $2,138,000 | +288.0% | 264,225 | +93.6% | 1.17% | +235.3% |
| Q1 2020 | $551,000 | – | 136,500 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|